mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.04 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.04 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.04 |